Amgen Valuation Overview

AMGN -- USA Stock  

USD 176.30  0.17  0.1%

Amgen shows prevailing Real Value of $166.91625 per share. The current price of the firm is $176.3. At this time the firm appears to be over valued. Macroaxis approximates value of Amgen from analyzing the firm fundamentals such as Profit Margin of 9.67% and Return On Equity of 9.59% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.

Valuation Drivers Correlation

Selected Amgen Valuation Data Over Time

Net Income Per Employee    Enterprise Value    Market Capitalization    
 Time Horizon     30 Days    Login   to change
Amgen is number one stock in last dividend paid category among related companies. It is rated third in price to sales category among related companies fabricating about  0.96  of Price to Sales per Last Dividend Paid. The ratio of Last Dividend Paid to Price to Sales for Amgen is roughly  1.04 

Current Market Valuation

Amgen Valuation Boundaries
Over Valued
May 22, 2018
Market Value
Real Value
Target Odds
Amgen is not too risky asset. Calculation of real value of Amgen is based on 1 month time horizon. Increasing Amgen time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Tax Efficiency

Amgen Tax Efficiency History

Tax Efficiency

Market Capitalization

Amgen Market Capitalization Analysis
Amgen is rated third in market capitalization category among related companies. Market capitalization of Pharmaceuticals And Biosciences industry is presently estimated at about 656.71 Billion. Amgen retains roughly 116.32 Billion in market capitalization claiming about 18% of equities listed under Pharmaceuticals And Biosciences industry.
Capitalization  Revenue  Workforce  Valuation  Total debt
Check also Trending Equities. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.